Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effectiveness of Edwards Lifesciences SAPIEN 3 Transcatheter Heart Valve (THV) in the Chinese Population

NCT03466918 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.

NCT NCT03466918
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03466918 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effectiveness of Edwards Lifesciences SAPIEN 3 Transcatheter Heart Valve (THV) in the Chinese Population
Lead sponsor
Edwards Lifesciences
Phase
Not applicable
Overall status
Completed
Start date
May 23, 2018
Completion date
June 19, 2024
Enrollment
58 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

aortic regurgitation, aortic stenosis, symptomatic aortic stenosis